Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 217 - 228 items out of 280 results
ILCN article
Regulating Artificial Intelligence
ILCN article
Experts Debate Addition of Frontline Chemotherapy for EGFR+ NSCLC
ILCN article
Should Biomarkers Be Used in the Clinical Management of ES-SCLC?
ILCN article
FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm
ILCN article
Antibody Drug Conjugates: Diamonds in the Rough?
ILCN article
The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
ILCN article
Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy
ILCN article
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
ILCN article
MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination
ILCN article
Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm?
ILCN article
Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt
ILCN article
More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care
Pagination
First
First page
‹
Previous page
…
15
16
17
18
19
20
21
22
23
…
›
Next page
Last
Last page